Evolus, Inc. (NASDAQ:EOLS - Get Free Report)'s stock price reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $8.82 and last traded at $8.78, with a volume of 1320192 shares. The stock had previously closed at $8.39.
Wall Street Analysts Forecast Growth
EOLS has been the subject of several recent analyst reports. Wall Street Zen upgraded shares of Evolus from a "hold" rating to a "buy" rating in a research report on Saturday, August 8th. Weiss Ratings raised shares of Evolus from a "sell (e+)" rating to a "sell (d-)" rating in a research report on Monday, June 15th. Finally, BTIG Research reiterated a "buy" rating and set a $13.00 price target on shares of Evolus in a research note on Wednesday, June 17th. Four equities research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Evolus presently has a consensus rating of "Moderate Buy" and a consensus target price of $14.50.
Read Our Latest Research Report on EOLS
Evolus Stock Up 4.6%
The company's fifty day moving average price is $6.86 and its two-hundred day moving average price is $5.80. The firm has a market cap of $579.92 million, a PE ratio of -16.88 and a beta of 1.35.
Institutional Trading of Evolus
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Larson Financial Group LLC raised its stake in Evolus by 136.6% during the fourth quarter. Larson Financial Group LLC now owns 4,914 shares of the company's stock worth $33,000 after purchasing an additional 2,837 shares during the period. Meeder Asset Management Inc. purchased a new stake in shares of Evolus during the 4th quarter valued at $34,000. Wexford Capital LP acquired a new stake in shares of Evolus during the 3rd quarter worth $37,000. California State Teachers Retirement System increased its holdings in shares of Evolus by 79.9% during the 2nd quarter. California State Teachers Retirement System now owns 5,455 shares of the company's stock worth $38,000 after buying an additional 2,423 shares during the last quarter. Finally, Legal & General Group Plc acquired a new stake in shares of Evolus during the 2nd quarter worth $40,000. Hedge funds and other institutional investors own 90.69% of the company's stock.
About Evolus
(
Get Free Report)
Evolus, Inc is a specialty pharmaceutical company focused on medical aesthetics. Headquartered in Newport Beach, California, Evolus develops and commercializes products designed to enhance facial appearance through minimally invasive procedures. Since its founding in 2017, the company has positioned itself in the fast-growing aesthetic market by partnering with leading manufacturers and leveraging clinical expertise to bring innovative injectables to practitioners and patients.
The company's flagship offering, Jeuveau (prabotulinumtoxinA-xvfs), is a neuromodulator approved by the U.S.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Evolus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evolus wasn't on the list.
While Evolus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
